Z3G-20669-44144
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 558 / MN
- Registered
- 2021-06-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-09
Registered in v-safe
-
2021-06-09
Dose 1 — Pfizer-BioNTech
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-12
- 2021-06-13
- 2021-06-14
- 2021-06-15
- 2021-06-16
- 2021-06-23
-
2021-07-01
Dose 2 — Pfizer-BioNTech
- 2021-07-01
- 2021-07-07
- 2021-07-08
- 2021-07-15
- 2021-07-23
- 2021-07-29
- 2021-08-05
- 2021-08-12
- 2021-10-01
-
2021-12-29
Dose 3 — Pfizer-BioNTech
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-04
- 2022-01-07
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-02-09
-
2022-12-31
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID Aug 2022MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-09 | Pfizer-BioNTech | |
| 2 | 2021-07-01 | Pfizer-BioNTech | No |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: COVID Aug 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release